Physician profile
Ashley Davios
NPI 1104583103
$1,124.77
in general payments reported to CMS, 2019-2025
13 companies · $635 in 2025
The $635 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $153 · 2024: $234 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $596.03 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $149.53 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $106.91 | 2022-2025 | Farxiga |
| Sanofi-Aventis U.S. LLC | $47.36 | 2022-2023 | |
| Amgen INC. | $38.34 | 2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $33.18 | 2024 | |
| Philips North America LLC | $28.20 | 2025 | Mcot |
| Recor Medical INC | $25.68 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bayer Healthcare Pharmaceuticals INC. | $25.41 | 2025 | |
| Abbott Laboratories | $23.23 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Kiniksa Pharmaceuticals International, Plc | $20.05 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $16.66 | 2022 | |
| Esperion Therapeutics, INC. | $14.19 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Davios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.